DrugPatentWatch Database Preview
Patent: 10,150,800
» See Plans and Pricing
Summary for Patent: 10,150,800
| Title: | EGFR-binding modular recognition domains |
| Abstract: | EGFR-binding modular recognition domains (MRDs) and complexes containing such MRDs linked to antibodies are described. The use of such MRDs and complexes are also described. |
| Inventor(s): | Roschke; Viktor (Bethesda, MD), Lafleur; David (Washington, DC), Hilbert; David M. (Bethesda, MD), Kiener; Peter (Potomac, MD) |
| Assignee: | Zyngenia, Inc. (Washington, DC) |
| Application Number: | 14/776,816 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,150,800
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Imclone | ERBITUX | cetuximab | VIAL; INTRAVENOUS | 125084 | 001 | 2004-06-18 | Start Trial | Zyngenia, Inc. (Washington, DC) | 2039-02-26 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 10,150,800
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201507118 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2014144600 | Start Trial |
| United States of America | 2016046678 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
